CHUANGLIAN HOLDINGS LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.019 HKD | 0.00% |
|
+5.56% | -9.52% |
| May. 09 | OPM Biosciences' Shareholder to Cut Stake | MT |
| Mar. 21 | Traffic Control Technology to Set Up 25 Million Yuan Joint Venture | MT |
Valuation
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 421.5 | 305.4 | 298.4 | 210.8 | 412.6 | 202.8 |
| Enterprise Value (EV) 1 | 340.2 | 222.7 | 311.2 | 171.4 | 340.3 | 133.1 |
| P/E ratio | -27.7 x | 40.1 x | -13.4 x | -102 x | 11.7 x | 15 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 3.25 x | 2.01 x | 1.81 x | 1.15 x | 1.47 x | 0.62 x |
| EV / Revenue | 2.62 x | 1.46 x | 1.89 x | 0.94 x | 1.21 x | 0.41 x |
| EV / EBITDA | 180 x | 15.6 x | 15.9 x | 7.52 x | 7.61 x | 3.57 x |
| EV / FCF | -209 x | -11.6 x | 64.2 x | 6.41 x | 17.7 x | -2.96 x |
| FCF Yield | -0.48% | -8.65% | 1.56% | 15.6% | 5.64% | -33.8% |
| Price to Book | 1.84 x | 1.22 x | 1.16 x | 0.82 x | 1.12 x | 0.52 x |
| Nbr of stocks (in thousands) | 4,642,511 | 4,968,511 | 5,962,211 | 5,962,211 | 6,752,211 | 6,752,211 |
| Reference price 2 | 0.0908 | 0.0615 | 0.0500 | 0.0353 | 0.0611 | 0.0300 |
| Announcement Date | 4/26/18 | 4/26/19 | 5/4/20 | 4/22/21 | 4/26/22 | 4/26/23 |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Net sales 1 | 129.8 | 152.1 | 164.9 | 183 | 280.3 | 325.6 |
| EBITDA 1 | 1.888 | 14.23 | 19.54 | 22.79 | 44.7 | 37.32 |
| EBIT 1 | -10.18 | 1.176 | 6.867 | 7.075 | 30.15 | 20.51 |
| Operating Margin | -7.85% | 0.77% | 4.16% | 3.87% | 10.76% | 6.3% |
| Earnings before Tax (EBT) 1 | -18.08 | 10.5 | -9.633 | 2.109 | 42.76 | 21.36 |
| Net income 1 | -15.23 | 7.588 | -20.2 | -2.059 | 33.01 | 13.52 |
| Net margin | -11.74% | 4.99% | -12.25% | -1.12% | 11.78% | 4.15% |
| EPS 2 | -0.003276 | 0.001531 | -0.003747 | -0.000345 | 0.005208 | 0.002002 |
| Free Cash Flow 1 | -1.63 | -19.25 | 4.846 | 26.76 | 19.19 | -44.93 |
| FCF margin | -1.26% | -12.66% | 2.94% | 14.62% | 6.85% | -13.8% |
| FCF Conversion (EBITDA) | - | - | 24.81% | 117.41% | 42.94% | - |
| FCF Conversion (Net income) | - | - | - | - | 58.15% | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 4/26/18 | 4/26/19 | 5/4/20 | 4/22/21 | 4/26/22 | 4/26/23 |
1CNY in Million2CNY
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | 12.8 | - | - | - |
| Net Cash position 1 | 81.3 | 82.7 | - | 39.4 | 72.3 | 69.6 |
| Leverage (Debt/EBITDA) | - | - | 0.6536 x | - | - | - |
| Free Cash Flow 1 | -1.63 | -19.3 | 4.85 | 26.8 | 19.2 | -44.9 |
| ROE (net income / shareholders' equity) | -10.6% | 2.56% | -7.65% | -1.13% | 9.46% | 2.86% |
| ROA (Net income/ Total Assets) | -2.04% | 0.24% | 1.14% | 0.99% | 3.71% | 2.28% |
| Assets 1 | 746.7 | 3,175 | -1,777 | -207.1 | 891 | 593.9 |
| Book Value Per Share 2 | 0.0500 | 0.0500 | 0.0400 | 0.0400 | 0.0500 | 0.0600 |
| Cash Flow per Share 2 | 0.0200 | 0.0200 | 0.0200 | 0.0200 | 0.0300 | 0.0200 |
| Capex 1 | 8.51 | 12.6 | 35 | 6.96 | 5.45 | 30.6 |
| Capex / Sales | 6.55% | 8.26% | 21.22% | 3.8% | 1.94% | 9.4% |
| Announcement Date | 4/26/18 | 4/26/19 | 5/4/20 | 4/22/21 | 4/26/22 | 4/26/23 |
1CNY in Million2CNY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -9.52% | 16.42M | |
| -21.67% | 2.9B | |
| +30.29% | 1.76B | |
| -53.19% | 1.63B | |
| -28.23% | 1.39B | |
| +21.81% | 820M | |
| -.--% | 813M | |
| +25.45% | 789M | |
| -4.60% | 678M | |
| -20.06% | 665M |
- Stock Market
- Equities
- 2371 Stock
- Financials Chuanglian Holdings Limited
